患者エンゲージメントにおけるAIの市場規模、シェア、動向分析レポート：技術別、提供タイプ別、機能別、治療領域別、最終用途別、地域別、セグメント予測、2024年～2030年

患者エンゲージメントにおけるAI市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の患者エンゲージメントにおけるAI市場規模は、2024年から2030年にかけて21.2％のCAGRを記録し、2030年までに231億米ドルに達する見込みです。

この市場を牽引しているのは、AIベースのパーソナライズされた治療計画やヘルスケア体験に対する需要の高まりと、デジタルプラットフォームの出現とオムニチャネルアプローチの必要性です。加えて、市場プレイヤーによる薬局の効率強化やサプライチェーンの複雑性の管理、ビジネス戦略における人工知能（AI）の役割の増大も、市場成長の原動力となっています。例えば、EmpiRx Health社は2024年5月、確立された技術を組み込んだ新しいAI搭載プラットフォーム「Clinically」を発表しました。このプラットフォームは薬局の請求処理と臨床評価を強化し、独自の集団健康エンジンを搭載しており、EmpiRx Healthの臨床重視の薬局給付管理（PBM）アプローチを強化しています。

さらに、糖尿病や高血圧などの慢性疾患の蔓延が拡大しているため、継続的な患者の関与と管理が必要となっており、AIはこれを効果的に促進することができます。さらに、機械学習や自然言語処理（NLP）などのAI技術は、パーソナライズされたサポートや介入を提供することで、患者エンゲージメントを大幅に強化することができます。これらの技術は患者データを分析し、オーダーメイドの推奨、リマインダー、教育コンテンツを提供し、アドヒアランスと健康アウトカムを改善します。例えば、ユニフォアは2022年3月、デジタル患者エンゲージメント・ソリューションのプロバイダーであるSpinSci Technologiesと戦略的パートナーシップを締結し、患者アクセスと医療提供者との相互作用を改善しました。この提携により、ユニフォアの会話AIと自動化技術が、電子カルテ（EHR）システムと互換性のあるSpinSci Technologiesの患者アクセスケアソリューションに統合されました。この統合は、コンタクトセンターのエージェントの効率を高め、患者のセルフサービス・ワークフローを合理化することを目的としています。

AIの統合により、医療機関は個々の患者の嗜好、ヘルスリテラシーのレベル、言語の習熟度に基づいて、オーダーメイドの教育コンテンツを提供することが可能になり、それによって患者のエンゲージメントと治療計画のアドヒアランスを向上させることができます。例えば、2024年2月、Accolade Groupが支援する新興プラットフォームAscendは、AIを活用して特定の要件に合わせた教育・ヘルスケアサービスを提供する意向を発表しました。このような取り組みの結果、患者教育機能セグメントは大幅な成長が見込まれ、今後数年間は市場全体の拡大を牽引することになります。

また、北米市場はAIの統合によって、ヘルスケア組織が個々の患者の嗜好、ヘルスリテラシーレベル、言語習熟度に基づいてオーダーメイドの教育コンテンツを提供できるようになり、それによって患者のエンゲージメントと治療計画のアドヒアランスが向上します。例えば、2024年2月、Accolade Groupが支援する新興プラットフォームAscendは、AIを活用して特定の要件に合わせた教育・ヘルスケアサービスを提供する意向を発表しました。このような取り組みの結果、患者教育機能セグメントは大幅な成長が見込まれ、今後数年間の市場全体の拡大を牽引することになります。

患者エンゲージメントにおけるAI市場のレポートハイライト

• 提供形態別では、クラウドベースのセグメントが市場を独占し、2023年の収益シェアは72.37%でした。クラウドベースのソリューションはスケーラブルなリソースを提供するため、ヘルスケア組織は需要の変動に応じてキャパシティを調整できます。
• 機能別では、コミュニケーション強化が2023年に25.84%の最大売上シェアを占めました。ヘルスケア分野でAI主導型ソリューションの統合が進んでいることが、コミュニケーション機能強化のニーズを後押ししています。
• 技術別では、自然言語処理（NLP）が2023年に88.82％の最大収益シェアを占めました。このセグメントの成長は、NLPモデルによって提供されるいくつかの利点、例えば、テーラーメイドで理解しやすい健康情報の提供による患者エンゲージメントと教育の改善などに起因しています。
• 治療分野別では、慢性疾患管理が2023年に64.87%の最大売上シェアを占めました。この分野の成長は、糖尿病、高血圧、心臓病などの慢性疾患の有病率の増加に起因しています。
• 最終用途別では、ヘルスケアプロバイダー分野が2023年に38.31%の最大収益シェアを占めました。患者中心のケアへの注目の高まりと、リソースの有効活用ニーズの高まり、パーソナライズされたヘルスケア体験への需要の高まりが、ヘルスケアプロバイダーが患者エンゲージメントのためにAIを導入する原動力となっています。
• 北米は2023年に43.60%のシェアを占め、市場を独占しました。この顕著なシェアの主な要因としては、高度なテクノロジーを備えた確立されたヘルスケアインフラの存在、AI対応患者エンゲージメント・ソリューションを統合する利点に対する意識の高まり、個別化されたヘルスケア体験と治療計画への嗜好の高まりなどが挙げられます。
• 同市場は複数のプレーヤーが存在するため断片化しています。このため、今後数年間は競合が激化すると予想されます。主な企業は、市場での地位を強化するために、新製品開発、提携、M&Aなどの戦略を採用するようになってきています。2024年6月、MedAdvisor SolutionsはAI対応プラットフォーム「Omnichannel Engagement for Pharmacy powered by THRiV」の発売を発表しました。このスイートにより、薬局はデジタル患者エンゲージメント戦略や、患者が好むペーパーレスオプションの提供など、既存の取り組みを強化することができます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 患者エンゲージメントにおけるAI市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• 患者エンゲージメント市場分析ツールにおける人工知能（AI）
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響
  • ケーススタディ

第4章 患者エンゲージメントにおけるAI市場の推定・動向分析：提供タイプ別

• 市場シェア、2023年と2030年
• セグメントダッシュボード
• 世界市場の展望
• クラウドベース
  • 2018年から2030年までの市場推計・予測
• オンプレミス
  • 2018年から2030年までの市場推計・予測

第5章 患者エンゲージメントにおけるAI市場の推定・動向分析：機能別

• 市場シェア、2023年と2030年
• セグメントダッシュボード
• 世界市場の展望
• 強化されたコミュニケーション
  • 2018年から2030年までの市場推計・予測
• 患者教育
  • 2018年から2030年までの市場推計・予測
• シャボットとバーチャルヘルスアシスタント
  • 2018年から2030年までの市場推計・予測
• 予測分析
  • 2018年から2030年までの市場推計・予測
• 管理と合理化された運用
  • 2018年から2030年までの市場推計・予測
• その他
  • 2018年から2030年までの市場推計・予測

第6章 患者エンゲージメントにおけるAI市場の推定・動向分析：技術タイプ別

• 市場シェア、2023年と2030年
• セグメントダッシュボード
• 世界市場の展望
• NLP
  • 2018年から2030年までの市場推計・予測
  • スマートアシスタンス
  • 光学文字認識（OCR）
  • 自動コーディング
  • テキスト分析
  • 音声分析
  • 分類とカテゴリー化
• その他
  • 2018年から2030年までの市場推計・予測

第7章 患者エンゲージメントにおけるAI市場の推定・動向分析：治療領域別

• 市場シェア、2023年と2030年
• セグメントダッシュボード
• 世界市場の展望
• 健康とウェルネス
  • 2018年から2030年までの市場推計・予測
• 慢性疾患管理
  • 2018年から2030年までの市場推計・予測
• その他
  • 2018年から2030年までの市場推計・予測

第8章 患者エンゲージメントにおけるAI市場の推定・動向分析：最終用途別

• 市場シェア、2023年と2030年
• セグメントダッシュボード
• 世界市場の展望
• ヘルスケア提供者
  • 2018年から2030年までの市場推計・予測
• ヘルスケア支払者
  • 2018年から2030年までの市場推計・予測
• その他
  • 製薬会社
  • 薬局

第9章 患者エンゲージメントにおけるAI市場の地域推定・動向分析、コンポーネント別、技術タイプ別

• 地域別市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 世界の地域市場スナップショット
• 市場規模、予測動向分析、2018年から2030年：
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • シンガポール
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• イノベーター
• ベンダー情勢
  • 主要企業の市場ポジション分析、2023年
  • Medadvisor Solutions
  • Innovaccer Inc.
  • EnlivenHealth（Omnicell）
  • EmpiRx Health
  • IBM.
  • Huma
  • mPulse Mobile
  • AllazoHealth
  • P360
  • Brand Engagement Network, Inc.
  • Oracle
  • Nuance Communications Inc.（Microsoft）
  • Health Catalyst
  • Ada Health GmbH
  • Aiva Inc.
  • Claritas Rx
  • AiCure
  • UST Global Inc.
  • ZS
  • IQVIA, Inc.

List of Tables

• Table 1 List of abbreviation
• Table 2 North America AI in patient engagement market, by region, 2018 - 2030 (USD Million)
• Table 3 North America AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 4 North America AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 5 North America AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 6 North America AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 7 North America AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 8 U.S. AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 9 U.S. AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 10 U.S. AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 11 U.S. AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 12 U.S. AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 13 Canada AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 14 Canada AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 15 Canada AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 16 Canada AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 17 Canada AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 18 Mexico AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 19 Mexico AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 20 Mexico AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 21 Mexico AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 22 Mexico AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 23 Europe AI in patient engagement market, by region, 2018 - 2030 (USD Million)
• Table 24 Europe AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 25 Europe AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 26 Europe AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 27 Europe AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 28 Europe AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 29 Germany AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 30 Germany AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 31 Germany AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 32 Germany AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 33 Germany AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 34 UK AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 35 UK AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 36 UK AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 37 UK AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 38 UK AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 39 France AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 40 France AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 41 France AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 42 France AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 43 France AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 44 Italy AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 45 Italy AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 46 Italy AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 47 Italy AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 48 Italy AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 49 Spain AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 50 Spain AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 51 Spain AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 52 Spain AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 53 Spain AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 54 Denmark AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 55 Denmark AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 56 Denmark AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 57 Denmark AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 58 Denmark AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 59 Sweden AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 60 Sweden AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 61 Sweden AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 62 Sweden AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 63 Sweden AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 64 Norway AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 65 Norway AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 66 Norway AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 67 Norway AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 68 Norway AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 69 Asia Pacific AI in patient engagement market, by region, 2018 - 2030 (USD Million)
• Table 70 Asia Pacific AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 71 Asia Pacific AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 72 Asia Pacific AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 73 Asia Pacific AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 74 Asia Pacific AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 75 China AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 76 China AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 77 China AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 78 China AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 79 China AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 80 Japan AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 81 Japan AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 82 Japan AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 83 Japan AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 84 Japan AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 85 India AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 86 India AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 87 India AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 88 India AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 89 India AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 90 South Korea AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 91 South Korea AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 92 South Korea AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 93 South Korea AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 94 South Korea AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 95 Australia AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 96 Australia AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 97 Australia AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 98 Australia AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 99 Australia AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 100 Thailand AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 101 Thailand AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 102 Thailand AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 103 Thailand AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 104 Thailand AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 105 Latin America AI in patient engagement market, by region, 2018 - 2030 (USD Million)
• Table 106 Latin America AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 107 Latin America AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 108 Latin America AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 109 Latin America AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 110 Latin America AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 111 Brazil AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 112 Brazil AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 113 Brazil AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 114 Brazil AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 115 Brazil AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 116 Argentina AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 117 Argentina AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 118 Argentina AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 119 Argentina AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 120 Argentina AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 121 MEA AI in patient engagement market, by region, 2018 - 2030 (USD Million)
• Table 122 MEA AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 123 MEA AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 124 MEA AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 125 MEA AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 126 MEA AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 127 South Africa AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 128 South Africa AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 129 South Africa AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 130 South Africa AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 131 South Africa AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 132 Saudi Arabia AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 133 Saudi Arabia AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 134 Saudi Arabia AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 135 Saudi Arabia AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 136 Saudi Arabia AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 137 UAE AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 138 UAE AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 139 UAE AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 140 UAE AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 141 UAE AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)
• Table 142 Kuwait AI in patient engagement market, by delivery mode, 2018 - 2030 (USD Million)
• Table 143 Kuwait AI in patient engagement market, by functionality, 2018 - 2030 (USD Million)
• Table 144 Kuwait AI in patient engagement market, by technology, 2018 - 2030 (USD Million)
• Table 145 Kuwait AI in patient engagement market, by therapeutic area, 2018 - 2030 (USD Million)
• Table 146 Kuwait AI in patient engagement market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Artificial intelligence in patient engagement market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Commodity flow analysis
• Fig. 5 Parent market analysis
• Fig. 6 Market snapshot
• Fig. 7 Segment snapshot
• Fig. 8 Segment snapshot
• Fig. 9 Segment snapshot
• Fig. 10 Competitive landscape snapshot
• Fig. 11 AI in Patient Engagement Market Dynamics
• Fig. 12 Major chatbot use cases in healthcare
• Fig. 13 Advantages of omnichannel for pharmaceutical industry
• Fig. 14 Key benefits of patient-centered care:
• Fig. 15 Key challenges and strategies to maximize the potential of conversational AI in healthcare
• Fig. 16 AI in patient engagement market: Porter's five forces analysis
• Fig. 17 AI in patient engagement market: PESTLE analysis
• Fig. 18 AI in patient engagement market, component outlook key takeaways (USD million)
• Fig. 19 AI in patient engagement market: Technology movement analysis, 2023 & 2030 (USD Million)
• Fig. 20 NLP market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Smart assistance market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 OCR market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Auto coding market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Text analytics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Speech analytics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Text analytics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 AI in patient engagement market, therapeutic outlook key takeaways (USD Million)
• Fig. 29 AI in patient engagement market: Therapeutic area movement analysis, 2023 & 2030 (USD Million)
• Fig. 30 Health & wellness market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Chronic disease management market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 AI in patient engagement market, functionality outlook key takeaways (USD Million)
• Fig. 34 AI in patient engagement market: Functionality movement analysis, 2023 & 2030 (USD Million)
• Fig. 35 Enhanced communication market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Patient education market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Chatbots and virtual health assistants market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Predictive analytics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Administrative and streamlined operations market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 AI in patient engagement market, delivery type outlook key takeaways (USD million)
• Fig. 42 AI in patient engagement market: Delivery type movement analysis, 2023 & 2030 (USD Million)
• Fig. 43 Cloud-based market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 On-premise market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 AI in patient engagement market, end use outlook key takeaways (USD Million)
• Fig. 46 AI in patient engagement market: End use movement analysis, 2023 & 2030 (USD Million)
• Fig. 47 Healthcare providers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Healthcare payers market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Regional outlook, 2023 & 2030
• Fig. 51 Regional marketplace: Key takeaways
• Fig. 52 Regional marketplace: Key takeaways
• Fig. 53 North America: SWOT Analysis
• Fig. 54 North America AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 55 U.S country dynamics
• Fig. 56 U.S. AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 57 Canada country dynamics
• Fig. 58 Canada AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 59 Mexico country dynamics
• Fig. 60 Mexico AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 61 Europe: SWOT Analysis
• Fig. 62 Europe AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 63 Germany country dynamics
• Fig. 64 Germany AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 65 France country dynamics
• Fig. 66 France AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 67 UK country dynamics
• Fig. 68 UK AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 69 Italy country dynamics
• Fig. 70 Italy AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 71 Spain country dynamics
• Fig. 72 Spain AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 73 Denmark country dynamics
• Fig. 74 Denmark AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 75 Sweden country dynamics
• Fig. 76 Sweden AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 77 Norway country dynamics
• Fig. 78 Norway AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 79 Asia Pacific: SWOT Analysis
• Fig. 80 Asia Pacific AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 81 Japan country dynamics
• Fig. 82 Japan AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 83 China country dynamics
• Fig. 84 China AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 85 India country dynamics
• Fig. 86 India AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 87 Australia country dynamics
• Fig. 88 Australia AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 89 South Korea country dynamics
• Fig. 90 South Korea AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 91 Thailand country dynamics
• Fig. 92 Thailand AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 93 Latin America: SWOT Analysis
• Fig. 94 Latin America AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 95 Brazil country dynamics
• Fig. 96 Brazil AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 97 Argentina country dynamics
• Fig. 98 Argentina AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 99 MEA: SWOT Analysis
• Fig. 100 MEA AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 101 South Africa country dynamics
• Fig. 102 South Africa AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 103 Saudi Arabia country dynamics
• Fig. 104 Saudi Arabia AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 105 UAE country dynamics
• Fig. 106 UAE AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 107 Kuwait country dynamics
• Fig. 108 Kuwait AI in patient engagement market, 2018 - 2030 (USD Million)
• Fig. 109 Key company categorization
• Fig. 110 Company market position analysis
• Fig. 111 Strategy mapping

AI In Patient Engagement Market Growth & Trends:

The global AI in patient engagement market size is expected to reach USD 23.1 billion by 2030, registering a CAGR of 21.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the growing demand for AI-based personalized treatment plans and healthcare experiences and the emergence of digital platforms and necessity for omnichannel approach. In addition, the increasing role of artificial intelligence (AI) in enhancing pharmacy efficiency and managing supply chain complexities and business strategies by market players is also driving the market growth. For instance, in May 2024, EmpiRx Health introduced Clinically, a new AI-powered platform that incorporates established technologies. This platform enhances pharmacy claims processing and clinical evaluations and includes a unique population health engine, reinforcing EmpiRx Health's clinical-focused Pharmacy Benefit Management (PBM) approach.

Moreover, the growing prevalence of chronic diseases, such as diabetes and hypertension, necessitates continuous patient engagement & management, which AI can effectively facilitate. Furthermore, AI technologies such as machine learning and natural language processing (NLP) can significantly enhance patient engagement by providing personalized support & interventions. These technologies analyze patient data to offer tailored recommendations, reminders, & educational content, improving adherence and health outcomes. For instance, in March 2022, Uniphore entered into a strategic partnership with SpinSci Technologies, a provider of digital patient engagement solutions, to improve patient access and interaction with healthcare providers. This collaboration integrated Uniphore's conversational AI and automation technology into SpinSci Technologies Patient Access Care solutions, which are compatible with Electronic Health Records (EHR) systems. The integration aimed to enhance efficiency for contact center agents and streamline patient self-service workflows.

The integration of AI enables healthcare organizations to deliver tailored educational content based on individual patient preferences, health literacy levels, and language proficiency, thereby improving patient engagement & adherence to treatment plans. For instance, in February 2024, Ascend, a startup platform backed by the Accolade Group, announced its intention to deliver educational and healthcare services tailored to specific requirements utilizing AI. As a result of such initiatives, the patient education functionality segment is expected to witness substantial growth, driving overall market expansion in the coming years.

In addition, the market in North America is driven by the integration of AI, enabling healthcare organizations to deliver tailored educational content based on individual patient preferences, health literacy levels, and language proficiency, thereby improving patient engagement & adherence to treatment plans. For instance, in February 2024, Ascend, a startup platform backed by the Accolade Group, announced its intention to deliver educational and healthcare services tailored to specific requirements utilizing AI. As a result of such initiatives, the patient education functionality segment is expected to witness substantial growth, driving overall market expansion in the coming years.

AI In Patient Engagement Market Report Highlights:

• On the basis of delivery mode, the cloud-based segment dominated the market and held a revenue share of 72.37% in 2023. Cloud-based solutions provide scalable resources, enabling healthcare organizations to adjust capacity according to demand fluctuations
• On the basis of functionality, enhanced communication held the largest revenue share of 25.84% in 2023. The growing integration of AI-driven solutions in the healthcare sector is driving the need for enhanced communication capabilities
• On the basis of technology, Natural Language Processing (NLP) held the largest revenue share of 88.82% in 2023. The segment growth can be attributed to several benefits offered by NLP models such as improved patient engagement and education through the provision of tailored & comprehensible health information
• On the basis of therapeutic area, chronic disease management held the largest revenue share of 64.87% in 2023. The segment growth can be attributed to the increasing prevalence of chronic conditions such as diabetes, hypertension, and heart disease
• On the basis of end use, the healthcare providers segment held the largest revenue share of 38.31% in 2023. The increasing focus on patient-centric care, coupled with the growing need for effective use of resources and a rising demand for personalized healthcare experiences, is driving healthcare providers to adopt AI for patient engagement
• North America dominated the market with a share of 43.60% in 2023. Key factors contributing to this notable share include the presence of a well-established healthcare infrastructure equipped with advanced technology, increasing awareness of the advantages of integrating AI-enabled patient engagement solutions, and a growing preference for personalized healthcare experiences & treatment plans
• The market is fragmented owing to the presence of several players. This is expected to intensify the competition in the coming years. Key companies are increasingly adopting strategies such as new product development, collaborations, and mergers & acquisitions to strengthen their market position. In June 2024, MedAdvisor Solutions announced the launch of Omnichannel Engagement for Pharmacy powered by THRiV, its AI-enabled platform. This suite enables pharmacies to enhance their digital patient engagement strategies and existing initiatives, including providing paperless options increasingly preferred by patients

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Technology
  • 1.1.2. Therapeutic Area
  • 1.1.3. Functionality
  • 1.1.4. Delivery Type
  • 1.1.5. End Use
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Technology Outlook
  • 2.2.2. Therapeutic Area Outlook
  • 2.2.3. Functionality Outlook
  • 2.2.4. Delivery Outlook
  • 2.2.5. End Use Outlook
  • 2.2.6. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Artificial Intelligence (AI) in Patient Engagement Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Artificial Intelligence (AI) in Patient Engagement Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Impact of COVID-19
  • 3.3.4. Case Study

Chapter 4. Artificial Intelligence (AI) in Patient Engagement Market Delivery Type Estimates & Trend Analysis

• 4.1. Delivery Type Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Artificial Intelligence (AI) in Patient Engagement Market by Delivery Type Outlook
• 4.4. Cloud-based
  • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. On-premise
  • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Artificial Intelligence (AI) in Patient Engagement Market Functionality Estimates & Trend Analysis

• 5.1. Functionality Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Artificial Intelligence (AI) in Patient Engagement Market by Functionality Outlook
• 5.4. Enhanced Communication
  • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. Patient Education
  • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.6. Chabot & Virtual Health Assistants
  • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.7. Predictive Analytics
  • 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.8. Administrative & Streamlined Operations
  • 5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Artificial Intelligence (AI) in Patient Engagement Market Technology Type Estimates & Trend Analysis

• 6.1. Technology Type Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Artificial Intelligence (AI) in Patient Engagement Market by Technology Type Outlook
• 6.4. NLP
  • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.4.2. Smart Assistance
    • 6.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.4.3. Optical Character Recognition (OCR)
    • 6.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.4.4. Auto Coding
    • 6.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.4.5. Text Analytics
    • 6.4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.4.6. Speech Analytics
    • 6.4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.4.7. Classification & Categorization
    • 6.4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.5. Others
  • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Artificial Intelligence (AI) in Patient Engagement Market Therapeutic Area Estimates & Trend Analysis

• 7.1. Therapeutic Area Market Share, 2023 & 2030
• 7.2. Segment Dashboard
• 7.3. Global Artificial Intelligence (AI) in Patient Engagement Market by Therapeutic Area Outlook
• 7.4. Health & Wellness
  • 7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 7.5. Chronic Disease Management
  • 7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 7.6. Others
  • 7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Artificial Intelligence (AI) in Patient Engagement Market End Use Estimates & Trend Analysis

• 8.1. End Use Market Share, 2023 & 2030
• 8.2. Segment Dashboard
• 8.3. Global Artificial Intelligence (AI) in Patient Engagement Market by End Use Outlook
• 8.4. Healthcare Provider
  • 8.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 8.5. Healthcare Payers
  • 8.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 8.6. Others
  • 8.6.1. Pharmaceutical Companies
    • 8.6.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 8.6.2. Pharmacy
    • 8.6.2.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 9. Artificial Intelligence (AI) in Patient Engagement Market Regional Estimates & Trend Analysis, By Component, By Technology Type

• 9.1. Regional Market Share Analysis, 2023 & 2030
• 9.2. Regional Market Dashboard
• 9.3. Global Regional Market Snapshot
• 9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 9.5. North America
  • 9.5.1. U.S.
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Regulatory framework/ reimbursement structure
    • 9.5.1.3. Competitive scenario
    • 9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.2. Canada
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework/ reimbursement structure
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.3. Mexico
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework/ reimbursement structure
    • 9.5.3.3. Competitive scenario
    • 9.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 9.6. Europe
  • 9.6.1. UK
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Regulatory framework/ reimbursement structure
    • 9.6.1.3. Competitive scenario
    • 9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.2. Germany
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework/ reimbursement structure
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.3. France
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Regulatory framework/ reimbursement structure
    • 9.6.3.3. Competitive scenario
    • 9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.4. Italy
    • 9.6.4.1. Key country dynamics
    • 9.6.4.2. Regulatory framework/ reimbursement structure
    • 9.6.4.3. Competitive scenario
    • 9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.5. Spain
    • 9.6.5.1. Key country dynamics
    • 9.6.5.2. Regulatory framework/ reimbursement structure
    • 9.6.5.3. Competitive scenario
    • 9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.6. Norway
    • 9.6.6.1. Key country dynamics
    • 9.6.6.2. Regulatory framework/ reimbursement structure
    • 9.6.6.3. Competitive scenario
    • 9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.7. Sweden
    • 9.6.7.1. Key country dynamics
    • 9.6.7.2. Regulatory framework/ reimbursement structure
    • 9.6.7.3. Competitive scenario
    • 9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.8. Denmark
    • 9.6.8.1. Key country dynamics
    • 9.6.8.2. Regulatory framework/ reimbursement structure
    • 9.6.8.3. Competitive scenario
    • 9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 9.7. Asia Pacific
  • 9.7.1. Japan
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Regulatory framework/ reimbursement structure
    • 9.7.1.3. Competitive scenario
    • 9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.2. China
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework/ reimbursement structure
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.3. India
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory framework/ reimbursement structure
    • 9.7.3.3. Competitive scenario
    • 9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.4. Australia
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Regulatory framework/ reimbursement structure
    • 9.7.4.3. Competitive scenario
    • 9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.5. South Korea
    • 9.7.5.1. Key country dynamics
    • 9.7.5.2. Regulatory framework/ reimbursement structure
    • 9.7.5.3. Competitive scenario
    • 9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.6. Singapore
    • 9.7.6.1. Key country dynamics
    • 9.7.6.2. Regulatory framework/ reimbursement structure
    • 9.7.6.3. Competitive scenario
    • 9.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
• 9.8. Latin America
  • 9.8.1. Brazil
    • 9.8.1.1. Key country dynamics
    • 9.8.1.2. Regulatory framework/ reimbursement structure
    • 9.8.1.3. Competitive scenario
    • 9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.2. Argentina
    • 9.8.2.1. Key country dynamics
    • 9.8.2.2. Regulatory framework/ reimbursement structure
    • 9.8.2.3. Competitive scenario
    • 9.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 9.9. MEA
  • 9.9.1. South Africa
    • 9.9.1.1. Key country dynamics
    • 9.9.1.2. Regulatory framework/ reimbursement structure
    • 9.9.1.3. Competitive scenario
    • 9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.2. Saudi Arabia
    • 9.9.2.1. Key country dynamics
    • 9.9.2.2. Regulatory framework/ reimbursement structure
    • 9.9.2.3. Competitive scenario
    • 9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.3. UAE
    • 9.9.3.1. Key country dynamics
    • 9.9.3.2. Regulatory framework/ reimbursement structure
    • 9.9.3.3. Competitive scenario
    • 9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.4. Kuwait
    • 9.9.4.1. Key country dynamics
    • 9.9.4.2. Regulatory framework/ reimbursement structure
    • 9.9.4.3. Competitive scenario
    • 9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company/Competition Categorization
• 10.3. Innovators
• 10.4. Vendor Landscape
  • 10.4.1. Key company market position analysis, 2023
  • 10.4.2. Medadvisor Solutions
    • 10.4.2.1. Company overview
    • 10.4.2.2. Financial performance
    • 10.4.2.3. Product benchmarking
    • 10.4.2.4. Strategic initiatives
  • 10.4.3. Innovaccer Inc.
    • 10.4.3.1. Company overview
    • 10.4.3.2. Financial performance
    • 10.4.3.3. Product benchmarking
    • 10.4.3.4. Strategic initiatives
  • 10.4.4. EnlivenHealth (Omnicell)
    • 10.4.4.1. Company overview
    • 10.4.4.2. Financial performance
    • 10.4.4.3. Product benchmarking
    • 10.4.4.4. Strategic initiatives
  • 10.4.5. EmpiRx Health
    • 10.4.5.1. Company overview
    • 10.4.5.2. Financial performance
    • 10.4.5.3. Product benchmarking
    • 10.4.5.4. Strategic initiatives
  • 10.4.6. IBM.
    • 10.4.6.1. Company overview
    • 10.4.6.2. Financial performance
    • 10.4.6.3. Product benchmarking
    • 10.4.6.4. Strategic initiatives
  • 10.4.7. Huma
    • 10.4.7.1. Company overview
    • 10.4.7.2. Financial performance
    • 10.4.7.3. Product benchmarking
    • 10.4.7.4. Strategic initiatives
  • 10.4.8. mPulse Mobile
    • 10.4.8.1. Company overview
    • 10.4.8.2. Financial performance
    • 10.4.8.3. Product benchmarking
    • 10.4.8.4. Strategic initiatives
  • 10.4.9. AllazoHealth
    • 10.4.9.1. Company overview
    • 10.4.9.2. Financial performance
    • 10.4.9.3. Product benchmarking
    • 10.4.9.4. Strategic initiatives
  • 10.4.10. P360
    • 10.4.10.1. Company overview
    • 10.4.10.2. Financial performance
    • 10.4.10.3. Product benchmarking
    • 10.4.10.4. Strategic initiatives
  • 10.4.11. Brand Engagement Network, Inc.
    • 10.4.11.1. Company overview
    • 10.4.11.2. Financial performance
    • 10.4.11.3. Product benchmarking
    • 10.4.11.4. Strategic initiatives
  • 10.4.12. Oracle
    • 10.4.12.1. Company overview
    • 10.4.12.2. Financial performance
    • 10.4.12.3. Product benchmarking
    • 10.4.12.4. Strategic initiatives
  • 10.4.13. Nuance Communications Inc. (Microsoft)
    • 10.4.13.1. Company overview
    • 10.4.13.2. Financial performance
    • 10.4.13.3. Product benchmarking
    • 10.4.13.4. Strategic initiatives
  • 10.4.14. Health Catalyst
    • 10.4.14.1. Company overview
    • 10.4.14.2. Financial performance
    • 10.4.14.3. Product benchmarking
    • 10.4.14.4. Strategic initiatives
  • 10.4.15. Ada Health GmbH
    • 10.4.15.1. Company overview
    • 10.4.15.2. Financial performance
    • 10.4.15.3. Product benchmarking
    • 10.4.15.4. Strategic initiatives
  • 10.4.16. Aiva Inc.
    • 10.4.16.1. Company overview
    • 10.4.16.2. Financial performance
    • 10.4.16.3. Product benchmarking
    • 10.4.16.4. Strategic initiatives
  • 10.4.17. Claritas Rx
    • 10.4.17.1. Company overview
    • 10.4.17.2. Financial performance
    • 10.4.17.3. Product benchmarking
    • 10.4.17.4. Strategic initiatives
  • 10.4.18. AiCure
    • 10.4.18.1. Company overview
    • 10.4.18.2. Financial performance
    • 10.4.18.3. Product benchmarking
    • 10.4.18.4. Strategic initiatives
  • 10.4.19. UST Global Inc.
    • 10.4.19.1. Company overview
    • 10.4.19.2. Financial performance
    • 10.4.19.3. Product benchmarking
    • 10.4.19.4. Strategic initiatives
  • 10.4.20. ZS
    • 10.4.20.1. Company overview
    • 10.4.20.2. Financial performance
    • 10.4.20.3. Product benchmarking
    • 10.4.20.4. Strategic initiatives
  • 10.4.21. IQVIA, Inc.
    • 10.4.21.1. Company overview
    • 10.4.21.2. Financial performance
    • 10.4.21.3. Product benchmarking
    • 10.4.21.4. Strategic initiatives